STAAR Surgical Share Holder Equity 2012-2026 | STAA
STAAR Surgical share holder equity from 2012 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
|
STAAR Surgical Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $344 |
| 2024 | $397 |
| 2023 | $386 |
| 2022 | $336 |
| 2021 | $259 |
| 2020 | $197 |
| 2019 | $160 |
| 2018 | $132 |
| 2017 | $43 |
| 2016 | $38 |
| 2015 | $39 |
| 2014 | $37 |
| 2013 | $39 |
| 2012 | $32 |
| 2011 | $29 |
|
STAAR Surgical Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2026-03-31 | $352 |
| 2025-12-31 | $344 |
| 2025-09-30 | $354 |
| 2025-06-30 | $337 |
| 2025-03-31 | $350 |
| 2024-12-31 | $397 |
| 2024-09-30 | $428 |
| 2024-06-30 | $409 |
| 2024-03-31 | $393 |
| 2023-12-31 | $386 |
| 2023-09-30 | $379 |
| 2023-06-30 | $354 |
| 2023-03-31 | $339 |
| 2022-12-31 | $336 |
| 2022-09-30 | $320 |
| 2022-06-30 | $299 |
| 2022-03-31 | $276 |
| 2021-12-31 | $259 |
| 2021-09-30 | $249 |
| 2021-06-30 | $235 |
| 2021-03-31 | $214 |
| 2020-12-31 | $197 |
| 2020-09-30 | $186 |
| 2020-06-30 | $175 |
| 2020-03-31 | $165 |
| 2019-12-31 | $160 |
| 2019-09-30 | $149 |
| 2019-06-30 | $144 |
| 2019-03-31 | $137 |
| 2018-12-31 | $132 |
| 2018-09-30 | $129 |
| 2018-06-30 | $51 |
| 2018-03-31 | $46 |
| 2017-12-31 | $43 |
| 2017-09-30 | $41 |
| 2017-06-30 | $38 |
| 2017-03-31 | $37 |
| 2016-12-31 | $38 |
| 2016-09-30 | $38 |
| 2016-06-30 | $38 |
| 2016-03-31 | $38 |
| 2015-12-31 | $39 |
| 2015-09-30 | $40 |
| 2015-06-30 | $40 |
| 2015-03-31 | $36 |
| 2014-12-31 | $37 |
| 2014-09-30 | $41 |
| 2014-06-30 | $42 |
| 2014-03-31 | $41 |
| 2013-12-31 | $39 |
| 2013-09-30 | $38 |
| 2013-06-30 | $35 |
| 2013-03-31 | $33 |
| 2012-12-31 | $32 |
| 2012-09-30 | $33 |
| 2012-06-30 | $31 |
| 2012-03-31 | $31 |
| 2011-12-31 | $29 |
| 2011-09-30 | $28 |
| 2011-06-30 | $26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.309B | $0.239B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |